A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy

Sydney Children's Hospital, Sydney

Royal Children's Hospital, Children's Neuroscience Centre, Parkville

Columbia University Medical Center, New York

Istituto Giannina Gaslini, Centro Traslazionale di Miologia e Patologie Neurodegenerative, Genova

Children's Hospital of Philadelphia - Neurology, Philadelphia

Duke Children's Hospital, Durham

Hospital Universitario La Paz, Pediatric Neurology Department, Madrid

Nemours Children's Hospital, Orlando

Universitatsklinikum Essen, Essen

Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago

Washington University School of Medicine, St Louis

Institut de Myologie, Paris

UT Southwestern Medical Center/Children's Medical Center Dallas, Dallas

Universtatsklinikum Freiburg, Zentrum fur Kinder-und Jugendmedizin , Abteilung Neuropadiatrie und Muskelerkrankungen, Freiburg im Breisgau

Children's Hospital Colorado, Aurora

Primary Children's Medical Center (University of Utah), Salt Lake City

UCLA Medical Center, Los Angeles

Doernbecher Children's Hospital, Portland

Boston Children's Hospital, Boston

Hôpital Universitaire des Enfants Reine FABIOLA (HUDERF), Brussels

British Columbia Children's Hospital/UBC, Vancouver

Hospital for Sick Children, Toronto

Pediatric Neurology Unit, Catholic University, Rome

Hyogo College of Medicine, Nishinomiya

Tokyo Women's Medical University, Tokyo

Seoul National University Hospital, Seoul

University of Gothenburg, The Queen Silvia Children's Hospital, Gothenburg

Hospital Universitario Vall d'Hebron, Barcelona

Hacettepe Children's Hospital, Ankara

UCL Institute of Child Health/Great Ormond Street, London

MRC Centre for Neuromuscular Diseases at Newcastle, Institute of Genetic Medicine Newcastle University, Newcastle